Forecasts by Type (Standalone, Partnership), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by Ownership (National/Regional, Universities, Non-Profit, Private), by Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Other), by Product and Service (Equipment, Consumables, Services, Software) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios
The Biobanking Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
A biobank is a place where biological materials that are connected to clinical data are stored. These samples are collected, handled, kept, and processed in compliance with quality standards to benefit society in some kind of a non-profit manner and to promote biomedical research. Large collections of information and biological samples known as biobanks were built specifically for the study. In a number of industries, which would include pharma, academic institutions, livestock breeding, and charitable foundations, these repositories are essential again for advances in medical science into illnesses pathologies as well as demographically experiments within areas of epigenetic mechanisms, preventive services medical programs, chronic illnesses, and epidemiology. Tumor specimens, umbilical, blood, and cerebral spinal fluid are just a few of the several places where biospecimens can be found.
Biobanks Have Emerged Due to Enormous Growth in Scientific Production in Biomedicine During the Past Five Years Biobanks have increased in size, number, and in some respects, speciation. Biospecimen source guides today include hundreds of biobanks, each with a unique business model for gathering, storing, disseminating, tagging, categorizing, and analyzing specimens (mostly originating from humans) for scientific study. The necessity to combine fundamental and clinical research by promoting cooperative models and the potential to boost informed consent effectiveness because the same genetic material may be used for different purposes led to the emergence of biobanks during the last five years.
What Questions Should You Ask before Buying a Market Research Report? • How is the biobanking market evolving? • What is driving and restraining the biobanking market? • How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032? • How will the market shares for each biobanking submarket develop from 2022 to 2032? • What will be the main driver for the overall market from 2022 to 2032? • Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032? • Who are the leading players and what are their prospects over the forecast period? • What are the biobanking projects for these leading companies? • How will the industry evolve during the period between 2020 and 2032? What are the implications of biobanking projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the biobanking market? • Where is the biobanking market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biobanking market today, and over the next 10 years: • Our 553-page report provides 359 tables and 317 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains an in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
The report delivers exclusive COVID-19 variations and economic data specific to your market.
Forecasts to 2032 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biobanking prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Market Segment by Type • Standalone • Partnership
Market Segment by Application • Regenerative Medicine • Life Science Research • Clinical Research
Market Segment by Sample Type • Blood Products • Human Tissues • Nucleic Acids • Cell Lines • Biological Fluids • Other Samples
Market Segment by Product and Service • Equipment • Consumables • Services • Software
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America • U.S. • Canada
Europe • Germany • UK • France • Italy • Spain • Russia • Denmark • Finland • Rest of Europe
Asia Pacific • China • Japan • India • Singapore • Australia • Rest of Asia Pacific
LAMEA • Brazil • Qatar • Saudi Arabia • Egypt • Mexico • Rest of Latin America
The report also includes profiles and for some of the leading companies in the Biobanking Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • AMS Biotechnology (Europe) Ltd. • ASKION GmbH • Avantor, Inc. • Azenta, Inc. (Azenta) • Bay Biosciences LLC • Bioivt & Elevating Science • Boca Biolistics • CTI Biotech • Cureline Inc. • Firalis SA • Geneticist Inc. • Hamilton Bonaduz AG • Isenet Biobanking • Merck & Co., Inc. • ProteoGenex Inc. • Qiagen NV • Stemcell Holdings, Inc. • STEMCELL Technologies Inc. • Thermo Fisher Scientific Inc. • US Biolab Corp. Inc.
Overall world revenue for Biobanking Market, 2022 to 2032 in terms of value the market will surpass US$59,347 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Biobanking Market, 2022 to 2032 report help you? In summary, our 550+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Biobanking Market, 2022 to 2032 Market, with forecasts for type, application, sample type, ownership, product and service, and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Biobanking Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Biobanking Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biobanking Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
Buy our report today Biobanking Market Report 2022-2032: Forecasts by Type (Standalone, Partnership), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by Ownership (National/Regional, Universities, Non-Profit, Private), by Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Other), by Product and Service (Equipment, Consumables, Services, Software) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview 1.1 Introduction to Biobanking Market 1.2 What are the Objectives of this Report? 1.3 What is the Scope of the Report? 1.4 Biobanking Market Definition 1.5 Why You Should Read This Report 1.6 What This Report Delivers 1.7 Key Questions Answered by This Analytical Report Include: 1.8 Who is This Report for? 1.9 Research Methodology 1.9.1 Primary Research 1.9.2 Secondary Research 1.9.3 Market Evaluation & Forecasting Methodology 1.10 Frequently Asked Questions (FAQs) 1.11 Associated Visiongain Reports 1.12 About Visiongain
2 Executive Summary
3 Biobanking Industry Structure 3.1 Overview 3.1.1 What is Biobank 3.1.2 Key features 3.1.3 Main Components of Biobanking 3.1.4 Types of Samples Collected in Biobanks 3.1.5 Types of Biobanks 3.1.6 History of Biobanks 3.1.7 Biobanking Operations 3.1.8 Objectives of a Biobank 3.1.9 Variability in Biobanks 3.1.10 Setting up a Biobank may be Difficult Given the Complexities of Biospecimen Handling And Maintenance 3.1.11 Biobanking in Health Care: Evolution and Future Directions
4 Global Market Dynamics 4.1 Current Trends in the Global Market 4.1.1 Investment in Information Communication Technologies to Drive Market Growth 4.1.2 Commercialisation of Biobanks’ Brings a Number of Potential Benefits 4.2 Market Driving Factors 4.2.1 Increased Focus on Precision Medicine and Genetic Testing 4.2.2 Growing Demand for Umbilical Cord Blood Banking 4.2.3 Evolution of Biobanks Rapidly Enabling Creation of Massive Collections of Biological Materials and Associated Information 4.3 Market Restraining Factors 4.3.1 Private Sponsorship Has Raised a Number of Ethical Issues 4.3.2 Issues Related to Biospecimen Sample Procurement 4.3.3 Challenges Related to Variability in Biobanks 4.4 Opportunities in the Global Market 4.4.1 Opportunities for Cardiovascular Research 4.4.2 The Pandemic Has Changed All Aspects of Biobanking Industry 4.4.3 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment 4.4.4 Growing Focus on the R&D of Cell Therapies 4.5 Challenges in the Global Market 4.5.1 Long-Term Sustainability of Biobanks 4.5.2 Biobanks Facing Familiar Challenges of Improving Design with Limited Resources 4.5.3 Academic Clinical Biobank's Business Plan Should Contain Risk Management and Risk Prognosis 4.6 SWOT Analysis for Global Market
5 Global Biobanking Market Analysis 5.1 Global Market Outlook 5.1.1 List of Biobanks Globally 5.2 Global Market Size Estimation and Forecast 5.2.1 Pre-COVID-19 Market Scenario 5.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
6 Global Market Size Estimation and Forecast by Region 6.1 Pre-COVID-19 Market Scenario 6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
7 Global Market Size Estimation and Forecast Biobank Type 7.1 Standalone 7.2 Partnership 7.3 Pre-COVID-19 Market Scenario 7.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
8 Global Market Size Estimation and by Application 8.1 Regenerative Medicine 8.2 Life Science Research 8.3 Clinical Research 8.3.1 Treatment Research 8.3.2 Prevention Research 8.3.3 Diagnostic Research 8.3.4 Screening Research 8.3.5 Quality of Life Research 8.3.6 Genetic studies 8.3.7 Epidemiological studies 8.4 Pre-COVID-19 Market Scenario 8.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
9 Global Market Size Estimation and Forecast by Ownership 9.1 National/ Regional 9.2 Universities 9.3 Private 9.4 Pre-COVID-19 Market Scenario 9.5 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
10 Global Market Size Estimation and Forecast by Sample Type 10.1 Blood Products 10.2 Human Tissues 10.3 Nucleic Acids 10.4 Cell Lines 10.5 Pre-COVID-19 Market Scenario 10.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
11 Global Market Size Estimation and Forecast Product and Service 11.1 Equipment 11.2 Consumables 11.3 Services 11.4 Software 11.5 Pre-COVID-19 Market Scenario 11.6 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12 North America Biobanking Market Analysis 12.1 North America Market Size Estimation and Forecast 12.1.1 Pre-COVID-19 Market Scenario 12.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.2 North America Market Size Estimation and Forecast by Country 12.2.1 Pre-COVID-19 Market Scenario 12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.3 North America Market Size Estimation and Forecast Type 12.3.1 Pre-COVID-19 Market Scenario 12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.4 North America Market Size Estimation and by "Application 12.4.1 Pre-COVID-19 Market Scenario 12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.5 North America Market Size Estimation and Forecast by Ownership 12.5.1 Pre-COVID-19 Market Scenario 12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.6 North America Market Size Estimation and Forecast by Sample Type 12.6.1 Pre-COVID-19 Market Scenario 12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.7 North America Market Size Estimation and Forecast Product and Service 12.7.1 Pre-COVID-19 Market Scenario 12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.8 U.S. Biobanking Market Analysis 12.8.1 Biobanking Research and Privacy Laws in the United States 12.8.2 BioLife Solutions Executes Co-Marketing Agreement with Coriell Institute 12.8.3 Pre-COVID-19 Market Scenario 12.8.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 12.9 Canada Biobanking Market Analysis 12.9.1 Pre-COVID-19 Market Scenario 12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13 Europe Biobanking Market Analysis 13.1 Europe Market Outlook 13.1.1 REPROCELL Signs Agency Agreement with Ajinomoto Group for the Marketing and Sales of StemFit Basic03 GMP 13.2 Europe Market Size Estimation and Forecast 13.2.1 Pre-COVID-19 Market Scenario 13.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.3 Europe Market Size Estimation and Forecast by Country 13.3.1 Pre-COVID-19 Market Scenario 13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.4 Europe Market Size Estimation and Forecast Type 13.4.1 Pre-COVID-19 Market Scenario 13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.5 Europe Market Size Estimation and by Application 13.5.1 Pre-COVID-19 Market Scenario 13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.6 Europe Market Size Estimation and Forecast by Ownership 13.6.1 Pre-COVID-19 Market Scenario 13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.7 Europe Market Size Estimation and Forecast by Sample Type 13.7.1 Pre-COVID-19 Market Scenario 13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.8 Europe Market Size Estimation and Forecast Product and Service 13.8.1 Pre-COVID-19 Market Scenario 13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.9 Germany Biobanking Market Analysis 13.9.1 Pre-COVID-19 Market Scenario 13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.10 UK Biobanking Market Analysis 13.10.1 Pre-COVID-19 Market Scenario 13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.11 France Biobanking Market Analysis 13.11.1 Pre-COVID-19 Market Scenario 13.11.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.12 Italy Biobanking Market Analysis 13.12.1 Pre-COVID-19 Market Scenario 13.12.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.13 Spain Biobanking Market Analysis 13.13.1 Pre-COVID-19 Market Scenario 13.13.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.14 Russia Biobanking Market Analysis 13.14.1 Pre-COVID-19 Market Scenario 13.14.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.15 Denmark Biobanking Market Analysis 13.15.1 Denmark Launches World-Class Biobank 13.15.2 Pre-COVID-19 Market Scenario 13.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.16 Finland Biobanking Market Analysis 13.16.1 FINGENIOUS® – A Digital Gateway to Finnish Biobanks And Biomedical Research 13.16.2 Pre-COVID-19 Market Scenario 13.16.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 13.17 Rest of Europe Biobanking Market Analysis 13.17.1 Switzerland Seeking to Join Six European Infrastructure Networks 13.17.2 Pre-COVID-19 Market Scenario 13.17.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14 Asia-Pacific Biobanking Market Analysis 14.1 Asia-Pacific Market Outlook 14.1.1 Six Government Agencies Work Together to Run the Korean Public Biobanks 14.2 Asia-Pacific Market Size Estimation and Forecast 14.2.1 Pre-COVID-19 Market Scenario 14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.3 Asia-Pacific Market Size Estimation and Forecast by Country 14.3.1 Pre-COVID-19 Market Scenario 14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.4 Asia-Pacific Market Size Estimation and Forecast Type 14.4.1 Pre-COVID-19 Market Scenario 14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.5 Asia-Pacific Market Size Estimation and by "Application 14.5.1 Pre-COVID-19 Market Scenario 14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.6 Asia-Pacific Market Size Estimation and Forecast by Ownership 14.6.1 Pre-COVID-19 Market Scenario 14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.7 Asia-Pacific Market Size Estimation and Forecast by Sample Type 14.7.1 Pre-COVID-19 Market Scenario 14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.8 Asia-Pacific Market Size Estimation and Forecast by Product and Service 14.8.1 Pre-COVID-19 Market Scenario 14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.9 China Biobanking Market Analysis 14.9.1 Rapid Expansion of Biobanking in China 14.9.2 Pre-COVID-19 Market Scenario 14.9.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.10 India Biobanking Market Analysis 14.10.1 Sapien Biosciences: India’s First Commercial Biobank That Helps Develop Novel Diagnostic Tests and Cures 14.10.2 Pre-COVID-19 Market Scenario 14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.11 Japan Biobanking Market Analysis 14.11.1 Nightingale and BioBank Japan to Realise Personalised Medicine and Preventative Health in Japan 14.11.2 Pre-COVID-19 Market Scenario 14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.12 Singapore Biobanking Market Analysis 14.12.1 Established Biobank in Singapore 14.12.2 BioBank - National Heart Centre Singapore 14.12.3 Pre-COVID-19 Market Scenario 14.12.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.13 Australia Biobanking Market Analysis 14.13.1 Australia’s First Accredited Biobank 14.13.2 NATA’s Biobanking Accreditation Set to Expand the Emerging Australian Biobanking Industry 14.13.3 Pre-COVID-19 Market Scenario 14.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 14.14 Rest of Asia-Pacific Biobanking Market Analysis 14.14.1 Taiwan Biobank: A Rich Biomedical Research Database of the Taiwanese Population 14.14.2 Pre-COVID-19 Market Scenario 14.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15 LAMEA Biobanking Market Analysis 15.1 LAMEA Market Outlook 15.1.1 Tumor Banking for Health Research in Brazil and Latin America 15.2 LAMEA Market Size Estimation and Forecast 15.2.1 Pre-COVID-19 Market Scenario 15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.3 LAMEA Market Size Estimation and Forecast by Country 15.3.1 Pre-COVID-19 Market Scenario 15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.4 LAMEA Market Size Estimation and Forecast Type 15.4.1 Pre-COVID-19 Market Scenario 15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.5 LAMEA Market Size Estimation and by Application 15.5.1 Pre-COVID-19 Market Scenario 15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.6 LAMEA Market Size Estimation and Forecast by Ownership 15.6.1 Pre-COVID-19 Market Scenario 15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.7 LAMEA Market Size Estimation and Forecast by Sample Type 15.7.1 Pre-COVID-19 Market Scenario 15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.8 LAMEA Market Size Estimation and Forecast Product and Service 15.8.1 Pre-COVID-19 Market Scenario 15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.9 Egypt Biobanking Market Analysis 15.9.1 Pre-COVID-19 Market Scenario 15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.10 Qatar Biobanking Market Analysis 15.10.1 Qatar Biobank Launches Online Portal to Provide Researchers with Bio-samples 15.10.2 Qatar Biobank research helps more than 190 projects 15.10.3 Pre-COVID-19 Market Scenario 15.10.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.11 Mexico Biobanking Market Analysis 15.11.1 Trans-Hit Bio Has Established New Collaborations With Mexican Biobanks 15.11.2 Pre-COVID-19 Market Scenario 15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.1 Brazil Biobanking Market Analysis 15.1.1 Current State of Biobanking Activities in Brazil 15.1.2 Pre-COVID-19 Market Scenario 15.1.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.2 Saudi Arabia Biobanking Market Analysis 15.2.1 Pre-COVID-19 Market Scenario 15.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis) 15.3 Rest of LAMEA Biobanking Market Analysis 15.3.1 Urgent Need for Management of Biological Samples and Data Accessibility in Latin America 15.3.2 Pre-COVID-19 Market Scenario 15.3.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
16 Company Profiles 16.1 QIAGEN 16.1.1 Company Snapshot 16.1.2 Company Overview 16.1.3 Company Financial Profile 16.1.4 Company Product Benchmarking 16.2 Merck & Co., Inc 16.2.1 Company Snapshot 16.2.2 Company Overview 16.2.3 Company Financial Profile 16.2.4 Company Product Benchmarking 16.3 Avantor Inc. 16.3.1 Company Snapshot 16.3.2 Company Overview 16.3.3 Company Financial Profile 16.3.4 Company Product Benchmarking 16.3.5 Company Recent Developments 16.4 STEMCELL Technologies Inc 16.4.1 Company Snapshot 16.4.2 Company Overview 16.4.3 Company Product Benchmarking 16.4.4 Company Recent Developments 16.5 Stemcell Holdings, Inc. 16.5.1 Company Snapshot 16.5.2 Company Overview 16.5.3 Company Product Benchmarking 16.6 Azenta Life Sciences 16.6.1 Company Snapshot 16.6.2 Company Overview 16.6.3 Company Financial Profile 16.6.4 Company Product Benchmarking 16.6.5 Company Recent Developments 16.7 AMS Biotechnology (Europe) Ltd. 16.7.1 Company Snapshot 16.7.2 Company Overview 16.7.3 Company Product Benchmarking 16.7.4 Company Recent Developments 16.8 ASKION GmbH 16.8.1 Company Snapshot 16.8.2 Company Overview 16.8.3 Company Product Benchmarking 16.8.4 Company Recent Developments 16.9 Bay Biosciences LLC 16.9.1 Company Snapshot 16.9.2 Company Overview 16.9.3 Company Product Benchmarking 16.9.4 Company Recent Developments 16.10 Cureline Inc. 16.10.1 Company Snapshot 16.10.2 Company Overview 16.10.3 Company Product Benchmarking 16.10.4 Company Recent Developments 16.11 Firalis SA. 16.11.1 Company Snapshot 16.11.2 Company Overview 16.11.3 Company Product Benchmarking 16.11.4 Company Recent Developments 16.12 Geneticist Inc.. 16.12.1 Company Snapshot 16.12.2 Company Overview 16.12.3 Company Product Benchmarking 16.12.4 Company Recent Developments 16.13 Hamilton Bonaduz AG 16.13.1 Company Snapshot 16.13.2 Company Overview 16.13.3 Company Product Benchmarking 16.13.4 Company Recent Developments 16.14 ProteoGenex Inc. 16.14.1 Company Snapshot 16.14.2 Company Overview 16.14.3 Company Product Benchmarking 16.14.4 Company Recent Developments 16.15 Thermo Fisher Scientific Inc. 16.15.1 Company Snapshot 16.15.2 Company Overview 16.15.3 Company Financial Profile 16.15.4 Company Product Benchmarking 16.15.5 Company Recent Developments 16.16 US Biolab Corp. Inc. 16.16.1 Company Snapshot 16.16.2 Company Overview 16.16.3 Company Product Benchmarking 16.17 BIOIVT & ELEVATING SCIENCE 16.17.1 Company Snapshot 16.17.2 Company Overview 16.17.3 Company Product Benchmarking 16.17.4 Company Recent Developments 16.18 Boca Biolistics 16.18.1 Company Snapshot 16.18.2 Company Overview 16.18.3 Company Product Benchmarking 16.18.4 Company Recent Developments 16.19 CTI Biotech 16.19.1 Company Snapshot 16.19.2 Company Overview 16.19.3 Company Product Benchmarking 16.19.4 Company Recent Developments 16.20 Isenet Biobanking 16.20.1 Company Snapshot 16.20.2 Company Overview 16.20.3 Company Product Benchmarking
17 Conclusion and Recommendations 17.1 Concluding Remarks 17.2 Recommendations for Market Players
List of Tables Table 1. Global Biobanking Market Snapshot, 2022 & 2032 (US$ million, CAGR %) Table 2. Biobanking Market Swot Analysis Table 3. Largest Biobanking In The World Table 4. List of Europe Biobank Table 5. List of North and Canada Biobanking Table 6. List of Asian Biobanks Table 7. Global Bio banking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 8. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 9. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 10. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 11. Global Biobanking Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 12. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 13. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 14. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 15. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 16. Global Biobanking Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 17. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 18. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 19. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 20. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 21. Global Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 22. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 23. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 24. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 25. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 26. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 27. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 28. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 29. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 30. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 31. Global Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 32. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 33. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 34. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 35. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 36. Global Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 37. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 38. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 39. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 40. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 41. Global Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 42. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 43. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 44. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 45. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 46. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 47. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 48. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 49. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 50. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 51. North America Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 52. North America Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 53. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 54. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 55. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 56. North America Bio banking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 57. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 58. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 59. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 60. Global Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 61. North America Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 62. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 63. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 64. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 65. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 66. North America Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 67. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 68. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 69. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 70. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 71. North America Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 72. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 73. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 74. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 75. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 76. North America Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 77. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 78. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 79. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 80. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 81. US Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 82. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 83. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 84. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 85. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 86. Canada Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 87. Europe Bio banking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 88. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 89. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 90. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 91. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 92. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 93. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 94. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 95. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 96. Europe Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 97. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 98. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 99. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 100. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 101. Europe Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 102. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 103. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 104. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 105. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 106. Europe Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 107. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 108. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 109. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 110. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 111. Europe Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 112. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 113. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 114. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 115. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 116. Europe Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 117. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 118. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 119. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 120. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 121. Europe Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 122. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 123. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 124. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 125. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 126. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 127. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 128. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 129. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 130. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 131. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 132. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 133. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 134. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 135. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 136. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 137. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 138. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 139. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 140. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 141. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 142. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 143. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 144. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 145. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 146. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 147. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 148. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 149. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 150. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 151. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 152. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 153. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 154. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 155. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 156. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 157. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 158. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 159. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 160. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 161. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 162. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 163. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 164. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 165. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 166. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 167. List of Asian Biobanks Table 168. Korean Biobank List Table 169. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 170. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 171. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 172. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 173. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 174. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 175. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 176. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 177. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 178. Asia-Pacific Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 179. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 180. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 181. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 182. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 183. Asia-Pacific Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 184. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 185. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 186. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 187. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 188. Asia-Pacific Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 189. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 190. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 191. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 192. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 193. Asia-Pacific Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 194. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 195. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 196. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 197. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 198. Asia-Pacific Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 199. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 200. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 201. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 202. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 203. Asia-Pacific Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 204. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 205. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 206. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 207. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 208. China Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 209. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 210. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 211. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 212. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 213. India Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 214. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 215. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 216. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 217. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 218. Japan Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 219. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 220. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 221. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 222. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 223. Singapore Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 224. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 225. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 226. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 227. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 228. Australia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 229. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 230. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 231. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 232. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 233. Rest of Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 234. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 235. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 236. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 237. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 238. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 239. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 240. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(V – Shaped Recovery) Table 241. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(W – Shaped Recovery) Table 242. LAMEA Biobanking Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))(U – Shaped Recovery) Table 243. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 244. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 245. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 246. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 247. LAMEA Biobanking Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 248. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 249. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 250. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 251. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 252. LAMEA Biobanking Market by Application, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 253. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 254. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 255. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 256. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 257. LAMEA Biobanking Market by Ownership, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 258. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 259. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 260. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 261. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 262. LAMEA Biobanking Market by Sample Type 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 263. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 264. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 265. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 266. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 267. LAMEA Biobanking Market by Product and Service, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 268. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 269. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 270. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 271. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 272. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 273. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 274. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 275. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 276. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 277. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 278. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 279. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery) Table 280. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery) Table 281. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery) Table 282. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery) Table 283. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 284. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V – Shaped Recovery) Table 285. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W – Shaped Recovery) Table 286. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U – Shaped Recovery) Table 287. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L – Shaped Recovery) Table 288. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 289. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 290. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 291. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 292. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 293. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 294. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 295. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 296. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 297. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) Table 298. Qiagen NV.: Company Information Table 299. Qiagen NV: Company Revenue 2017-2021 (US$Mn, AGR %) Table 300. Qiagen NV.: Company Product and Service Benchmarking Table 301. Merck & Co: Company Information Table 302. Merck & Co: Company Revenue 2017-2021 (US$Mn, AGR %) Table 303. Merck & Co: Company Product and Service Benchmarking Table 304. Avantor, Inc.: Company Information Table 305. Avantor, Inc: Company Revenue 2017-2021 (US$Mn) Table 306. Avantor, Inc.: Company Product and Service Benchmarking Table 307. Avantor Inc: Company Recent Developments Table 308. STEMCELL Technologies Inc.: Company Information Table 309. STEMCELL Technologies Inc.: Company Product and Service Benchmarking Table 310. STEMCELL Technologies Inc.: Company Recent Developments Table 311. Stemcell Holdings, Inc.: Company Information Table 312. Stemcell Holdings, Inc: Company Product and Service Benchmarking Table 313. Azenta, Inc.: Company Information Table 314. Azenta, Inc: Company Revenue 2017-2021 (US$Mn, AGR %) Table 315. Azenta, Inc.: Company Product and Service Benchmarking Table 316. Azenta, Inc.: Company Recent Developments Table 317. AMS Biotechnology (Europe) Ltd.: Company Information Table 318. AMS Biotechnology (Europe) Ltd.: Company Product and Service Benchmarking Table 319. AMS Biotechnology (Europe) Ltd.: Company Recent Developments Table 320. ASKION GmbH: Company Information Table 321. ASKION GmbH: Company Product and Service Benchmarking Table 322. ASKION GmbH: Company Recent Developments Table 323. Bay Biosciences LLC: Company Information Table 324. Bay Biosciences LLC: Company Product and Service Benchmarking Table 325. Bay Biosciences LLC: Company Recent Developments Table 326. Cureline Inc.: Company Information Table 327. Cureline Inc.: Company Product and Service Benchmarking Table 328. Cureline Inc.: Company Recent Developments Table 329. Firalis SA.: Company Information Table 330. Firalis SA.: Company Product and Service Benchmarking Table 331. Firalis SA.: Company Recent Developments Table 332. Geneticist Inc..: Company Information Table 333. Geneticist Inc..: Company Product and Service Benchmarking Table 334. Geneticist Inc..: Company Recent Developments Table 335. Hamilton Bonaduz AG: Company Information Table 336. Hamilton Bonaduz AG: Company Product and Service Benchmarking Table 337. Hamilton Bonaduz AG: Company Recent Developments Table 338. ProteoGenex Inc.: Company Information Table 339. ProteoGenex Inc.: Company Product and Service Benchmarking Table 340. ProteoGenex Inc.: Company Recent Developments Table 341. Thermo Fisher Scientific Inc..: Company Information Table 342. Thermo Fisher Scientific Inc..: Company Revenue 2017-2021 (US$Mn, AGR %) Table 343. Thermo Fisher Scientific Inc..: Company Product and Service Benchmarking Table 344. Thermo Fisher Scientific Inc..: Company Recent Developments Table 345. US Biolab Corp. Inc.: Company Information Table 346. US Biolab Corp. Inc.: Company Product and Service Benchmarking Table 347. BIOIVT & ELEVATING SCIENCE.: Company Information Table 348. BIOIVT & ELEVATING SCIENCE.: Company Product and Service Benchmarking Table 349. BIOIVT & ELEVATING SCIENCE.: Company Recent Developments Table 350. Boca Biolistics.: Company Information Table 351. Boca Biolistics.: Company Product and Service Benchmarking Table 352. Boca Biolistics.: Company Recent Developments Table 353. CTI Biotech.: Company Information Table 354. CTI Biotech.: Company Product and Service Benchmarking Table 355. CTI Biotech.: Company Recent Developments Table 356. Isenet Biobanking.: Company Information Table 357. Isenet Biobanking.: Company Product and Service Benchmarking
List of Figures Figure 1. Global Biobanking Market Segmentation Figure 2. Current Trends in the Global Market Figure 3. Global Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%)) Figure 4. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 5. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 6. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 7. Global Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 8. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%)) Figure 9. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 10. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery) Figure 11. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery) Figure 12. Global Biobanking Market by Region, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery) Figure 13. Global Biobanking Market Forecast by Type 2022, 2027, 2032 (%) Figure 14. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) Figure 15. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 16. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 17. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 18. Global Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 19. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%)) Figure 20. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 21. Global Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 22. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 23. Global Biobanking Market by "Application2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 24. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) Figure 25. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 26. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 27. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 28. Global Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 29. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) Figure 30. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 31. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 32. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 33. Global Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 34. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) Figure 35. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 36. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 37. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 38. Global Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 39. North America Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%)) Figure 40. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 41. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 42. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 43. North America Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 44. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%)) Figure 45. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 46. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery) Figure 47. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery) Figure 48. North America Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery) Figure 49. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) Figure 50. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 51. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 52. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 53. North America Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 54. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) Figure 55. North America Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 56. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 57. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 58. North America Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 59. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) Figure 60. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 61. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 62. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 63. North America Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 64. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) Figure 65. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 66. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 67. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 68. North America Biobanking Market by Sample Type , 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 69. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) Figure 70. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 71. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 72. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 73. North America Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 74. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 75. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 76. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 77. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 78. US Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 79. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 80. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 81. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 82. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 83. Canada Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 84. Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%)) Figure 85. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 86. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 87. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 88. Europe Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 89. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%)) Figure 90. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 91. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery) Figure 92. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery) Figure 93. Europe Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery) Figure 94. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) Figure 95. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 96. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 97. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 98. Europe Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 99. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) Figure 100. Europe Biobanking Market by Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 101. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 102. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 103. Europe Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 104. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) Figure 105. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 106. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 107. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 108. Europe Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 109. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) Figure 110. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 111. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 112. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 113. Europe Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 114. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) Figure 115. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 116. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 117. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 118. Europe Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 119. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 120. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 121. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 122. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 123. Germany Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 124. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 125. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 126. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 127. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 128. UK Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 129. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 130. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 131. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 132. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 133. France Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 134. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 135. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 136. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 137. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 138. Italy Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 139. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 140. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 141. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 142. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 143. Spain Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 144. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 145. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 146. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 147. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 148. Russia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 149. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 150. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 151. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 152. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 153. Denmark Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 154. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 155. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 156. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 157. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 158. Finland Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 159. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 160. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 161. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 162. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 163. Rest of Europe Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 164. Asia-Pacific Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%)) Figure 165. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 166. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 167. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 168. Asia-Pacific Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 169. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%)) Figure 170. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 171. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery) Figure 172. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery) Figure 173. Asia-Pacific Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery) Figure 174. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) Figure 175. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 176. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 177. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 178. Asia-Pacific Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 179. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) Figure 180. Asia-Pacific Biobanking Market by "Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 181. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 182. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 183. Asia-Pacific Biobanking Market by "Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 184. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) Figure 185. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 186. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 187. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 188. Asia-Pacific Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 189. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) Figure 190. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 191. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 192. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 193. Asia-Pacific Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 194. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) Figure 195. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 196. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 197. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 198. Asia-Pacific Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 199. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 200. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 201. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 202. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 203. China Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 204. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 205. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 206. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 207. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 208. India Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 209. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 210. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 211. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 212. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 213. Japan Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 214. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 215. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 216. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 217. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 218. Singapore Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 219. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 220. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 221. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 222. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 223. Australia Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 224. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) Figure 225. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 226. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 227. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 228. Rest of Asia-Pacific Biobanking Market by Value, 2021-2031 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 229. LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR(%)) Figure 230. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 231. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 232. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 233. LAMEA Biobanking Market by Value, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 234. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%)) Figure 235. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 236. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(W – Shaped Recovery) Figure 237. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(U – Shaped Recovery) Figure 238. LAMEA Biobanking Market by Country, 2022-2032(USD Mn, AGR(%))(L – Shaped Recovery) Figure 239. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) Figure 240. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (V – Shaped Recovery) Figure 241. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 242. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 243. LAMEA Biobanking Market by Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 244. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) Figure 245. LAMEA Biobanking Market by Application2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 246. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 247. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 248. LAMEA Biobanking Market by Application 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 249. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) Figure 250. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 251. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 252. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 253. LAMEA Biobanking Market by Ownership, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 254. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) Figure 255. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 256. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 257. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 258. LAMEA Biobanking Market by Sample Type, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 259. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) Figure 260. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%))(V – Shaped Recovery) Figure 261. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (W – Shaped Recovery) Figure 262. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (U – Shaped Recovery) Figure 263. LAMEA Biobanking Market by Product and Service, 2022-2032(USD Mn, AGR(%)) (L – Shaped Recovery) Figure 264. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 265. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 266. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 267. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 268. Egypt Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 269. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 270. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 271. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 272. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 273. Qatar Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 274. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 275. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 276. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))(W – Shaped Recovery) Figure 277. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 278. Mexico Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 279. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 280. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%))(V – Shaped Recovery) Figure 281. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 282. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 283. Brazil Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 284. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 285. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 286. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 287. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 288. Saudi Arabia Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 289. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) Figure 290. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (V – Shaped Recovery) Figure 291. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (W – Shaped Recovery) Figure 292. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (U – Shaped Recovery) Figure 293. Rest of LAMEA Biobanking Market by Value, 2022-2032 (USD Mn, AGR (%)) (L – Shaped Recovery) Figure 294. Qiagen NV: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 295. Qiagen NV: Company Operating Income 2017-2021 (US$Mn, AGR %) Figure 296. Qiagen NV: Company Net Income 2017-2021 (US$Mn, AGR %) Figure 297. Qiagen NV: Company EBITDA 2017-2021 (US$Mn, AGR %) Figure 298. Merck & Co: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 299. Merck & Co: Company Operating Income 2017-2021 (US$Mn, AGR %) Figure 300. Merck & Co: Company Net Income 2017-2021 (US$Mn, AGR %) Figure 301. Merck & Co: Company EBITDA 2017-2021 (US$Mn, AGR %) Figure 302. Azenta, Inc: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 303. Azenta, Inc: Company Operating Income 2017-2021 (US$Mn, AGR %) Figure 304. Azenta, Inc: Company Net Income 2017-2021 (US$Mn, AGR %) Figure 305. Azenta, Inc..: Company EBITDA 2017-2021 (US$Mn, AGR %) Figure 306. Thermo Fisher Scientific Inc..: Company Revenue 2017-2021 (US$Mn, AGR %) Figure 307. Thermo Fisher Scientific Inc..: Company Operating Income 2017-2021 (US$Mn, AGR %) Figure 308. Thermo Fisher Scientific Inc..: Company Net Income 2017-2021 (US$Mn, AGR %) Figure 309. Thermo Fisher Scientific Inc..: Company EBITDA 2017-2021 (US$Mn, AGR %)
List of Companies Profiled in the report AMS Biotechnology (Europe) Ltd. ASKION GmbH Avantor, Inc. Azenta, Inc. (Azenta) Bay Biosciences LLC Bioivt & Elevating Science Boca Biolistics CTI Biotech Cureline Inc. Firalis SA Geneticist Inc. Hamilton Bonaduz AG Isenet Biobanking Merck & Co., Inc. ProteoGenex Inc. Qiagen NV Stemcell Holdings, Inc. STEMCELL Technologies Inc. Thermo Fisher Scientific Inc. US Biolab Corp. Inc.
List of Other Companies Mentioned in the report American CryoStem Asterand Bioscience Aurora Biomed Autoscribe Informatics AuxoCell Laboratories AXM Shenyang BioCells BIOVIA Caladrius Biosciences California Cryobank Stem Cell Services LLC Cells4Life Inbiomed Indivumed IntegenX International Stem Cell Corporation LifeGene OriGene Pacific BioStorage Panasonic Biomedical Parelsnoer Pharma Cells Pharmacells Group Pharmagene Pop-Gen National Cohort Popgen Precision Bioservices ProMedDx ProteoGenex StarLIMS Steelgate Stellacure StemCyte Stemgent StemSave ViaCord VidaPlus
List of Associations Mentioned in the Report American Association of Tissue Banks Australasian Biospecimen Network (ABN) Bavarian Red Cross (BRK) Biobank Ireland Trust Centro Nazionale per le Risorse Biologiche (CNRB) Coriell Institute for Medical Research European Association for Predictive, Preventative & Personalised Medicine (EPMA) European Health Risk Monitoring (EHRM) Food and Drug Administration (FDA) Harvard University INSERM Instituto de Salud Carlos III International Agency for Research on Cancer (IARC) International Air Transport Association (IATA) International Society for Biological and Environmental Repositories (ISBER) National Cancer Institute (NCI) National Genome Research Network (NGFN) National Institutes of General Medical Sciences Northeastern University Office of Biorepositories and Biospecimen Research (OBBR) Russian Society for Biobanking and Biopreservation (RSBB) Sechenov First Moscow Medical University (SFMMU) Singapore Biobank (SBB) Singapore Tissue Network (STN) Spanish National Biobank Network The Organisation for Economic Co-operation and Development (OECD) UK Biobank US Department of Transportation (DOT) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Biobanking Market Report 2022-2032
Factors such as rising prevalence of chronic and genetic diseases, increasing application areas of stem cell technologies, technological advancements, and...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
